Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Email

NCI SBIR at Princeton Innovation Center BioLabs

November 5, 2026 | 12:00 PM – 4:00 PM

Princeton, NJ

Add to Outlook Calendar

​Are you aware of the federal funding program that supports the commercialization efforts of biotech innovators? The Small Business Innovation Research (SBIR) program at the National Cancer Institute (NCI) provides over $200 million annually in funding to small businesses developing innovative cancer technologies.

​As part of NCI’s engine of innovation for advancing novel cancer-related technologies from lab to market, the SBIR Development Center funds a diverse portfolio of small businesses that are developing technologies to prevent, diagnose, and treat cancer.

​The in-person seminar will be held from 12:00 pm to 1:30 pm, followed by the 1:1 meetings from 1:30 pm to 4:00 pm. The program will cover funding opportunities for oncology startups, academic spinout companies, and early-stage academic entrepreneurs, as well as tips for writing competitive grant proposals and commercialization resources for applicants and awardees.

​Speakers
Julianne Twomey, PhD, joined the NCI Small Business Innovation Research (SBIR) Development Center as a program director in January 2025. She manages a portfolio of small businesses focused on developing anticancer therapeutics.

Ming Zhao, PhD, is a program director at the National Cancer Institute’s Small Business Innovation Research (SBIR) Development Center. In this role, he develops and manages SBIR/STTR programs and contracts focused on cancer therapeutics, molecular diagnostics, medical imaging, radiotherapy, and AI-aided technology development.

After the presentation, participants will have the opportunity to engage in 1:1 20-minute meetings with NCI SBIR Program Directors Julianne Twomey, PhD, and Ming Zhao, PhD, to discuss their cancer technology projects and potential fit with NCI SBIR/STTR funding opportunities. Come with prepared questions, a pitch deck or specific aims page on your technology. Pre-registration is a must; limited spots available. Register here.

Email